📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer. (2023)

First Author: Wills C

Attributed to: Method Meta-analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/gcc.23133

PubMed Identifier: 36790221

Publication URI: http://europepmc.org/abstract/MED/36790221

Type: Journal Article/Review

Volume: 62

Parent Publication: Genes, chromosomes & cancer

Issue: 6

ISSN: 1045-2257